This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Life Technologies Says Demand Held Up In 3Q

CARLSBAD, Calif. (AP) ¿ Life Technologies Corp., a life sciences and medical research tools company, said Tuesday that demand for its products was solid in the third quarter, and economic stimulus funds encouraged greater sales.

The company also raised its profit forecast for the full year, and its shares reached an annual high in morning trading.

Life Technologies was formed in November 2008, after Invitrogen Corp. bought Applied Biosystems Inc. for $6.4 billion. Leaving out costs connected to the acquisition and integration of Applied Biosystems, the company said it earned 73 cents per share in the third quarter, matching estimates from analysts surveyed by Thomson Reuters, who typically exclude costs.

Revenue totaled $805.1 million ¿ or 3 percent greater than the combined sales of Invitrogen and Applied Biosystems in the third quarter of 2008. The company said molecular biology system revenue grew 5 percent to $394 million, while genetic systems revenue rose 5 percent to $216 million and cell system revenue slid 3 percent to $189 million.

Analysts expected $805.1 million in revenue.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ABI $22.98 1.01%
LIFE $24.71 0.00%
DHR $86.61 0.00%
AAPL $132.54 0.00%
FB $80.54 0.00%

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs